Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by biorunon Jun 22, 2021 8:58am
154 Views
Post# 33426184

RE:Getting Ugly

RE:Getting Ugly

Setting these kind of milestones dates is highly risky at the best of times in regular industry nevermind the unpredictability of biotech.

Did the mob here ever think that the dates were established based upon pre-established contract decision dates, signed under nda, therefore derisking significantly here? Did any of the dumb dumbs here think about that?

Whatever we may say about empty promises, one thing I do know for absolute certain is that there is a high probability the CEO is not only intellectually 2 steps ahead of you here on how this will play out, he is also smart enough to not compromise the sanctity of his sizeable investment and commitment to seeing the company through to this "next era." Yes, he may be a bad linear widget growth manager, but his IQ is absolutely higher. The plan here, in case you didn't know, is that a number of strategic agreements are to be put in place which aim to fundamentally wrap all the Geraldine IP in commercial viability.

Eventual buyout at much much higher value is in play. That is the role of junior biotech in the big space, and that is why the big players pay the big money to acquire scientific platforms and portfolios. It is not to grow a self sustaining widget factory and drive PL statements quarter over quarter.

And no, if there is an nda in place, there is NO obligation to tell us.

I am looking very much forward to the day, maybe soon, maybe not, where everything on the table comes to light, and perhaps a few may develop deep regret for their ongoing stupidity in their role in fueling the frustration and unnecessarily scaring off investors with their demands on this board, and to a lesser extent on Twitter.

By the way, the complaining is doing nothing. It is not in any way changing anything except driving the price down 500 shares at a time.

So do what you want, but please stop chanting with your signs and demanding heads to roll. The strategy does not work in this case.

My simple view is that you think about the science in a dark room, then come out - if you take a preschool crayon and draw a line from the first low point on the 10 yr chart to the next two low points, you will see an upward trend and realize we may be at that buy now window as we speak. 



 

<< Previous
Bullboard Posts
Next >>